Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Alkermes Invests In Novel CNS Targets With Rodin Acquisition

Mon, 11/18/2019 - 11:45am

Rodin is developing HDAC CoREST complex inhibitors for neurological conditions, with a lead candidate having completed Phase I testing. Alkermes...

      Related Stories 

Zealand Pharma Preps Pipeline For Catalyst-Filled 2020

Mon, 11/18/2019 - 7:54am

Zealand Pharma’s recently installed CEO says it is building US operations to prepare for four potential approvals there in 2020...

      Related Stories 

FDA Approval For Novartis’s Sickle Cell Treatment Adakveo

Mon, 11/18/2019 - 3:50am

One of a new wave of treatments, Novartis has focused on proving its drug cuts vaso-occlusive crises (VOCs), or pain...

      Related Stories 

FDA Approval For Novartis’ Sickle Cell Treatment Adakveo

Mon, 11/18/2019 - 3:50am

One of a new wave of treatments, Novartis has focused on proving its drug cuts vaso-occlusive crises (VOCs), or pain...

      Related Stories 

Pipeline Watch: Lumasiran, Empagliflozin Major Clinical Trial Starts

Mon, 11/18/2019 - 2:10am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Monroe Site Commercialization ‘Critical’ For Glenmark’s US Step-Up

Sun, 11/17/2019 - 3:29pm

Glenmark expects its first US manufacturing site to go commercial next year, accelerating growth in that market, while it sets...

      Related Stories 

ResTORbio Pins Hopes On Parkinson’s After Failed CSRI Study

Fri, 11/15/2019 - 2:43pm

Company terminates studies of its TORC1 blocker after it fails to prevent respiratory illness in elderly patients with clinically symptomatic...

      Related Stories 

Roche Paying $390m Up Front For Fibrosis-Fighting Promedior

Fri, 11/15/2019 - 1:56pm

The deal, which includes up to $1bn for milestones, gives Roche Promedior’s PRM-151, a Phase III-ready asset for IPF that...

      Related Stories 

NASH Companies Take The Stage At AASLD

Fri, 11/15/2019 - 1:44pm

NGM’s injectable might be best-suited as induction therapy for sicker NASH patients, Inventiva hopes its pan-PPAR agonist will outperform Genfit’s...

      Related Stories 

Amarin Heads Into Vascepa Expansion Labeling Talks After Positive US FDA Panel Review

Fri, 11/15/2019 - 1:24pm

Focus of negotiations with agency will be on breadth of population encompassed by a cardiovascular risk reduction indication; most advisory...

      Related Stories 

BioMarin’s Momentum Grows With Twin Blockbuster Plans

Fri, 11/15/2019 - 7:24am

The frontrunner in hemophilia A gene therapy has been hit by data doubts, but this and achondroplasia drug could deliver...

      Related Stories 

Double Delight For Novartis At The CHMP

Fri, 11/15/2019 - 6:21am

Novartis has received two positive opinions in Europe, the most important being for Mayzent, its active secondary progressive multiple sclerosis...

      Related Stories 

Women In High Places: Slow Progress In Pharma

Fri, 11/15/2019 - 12:36am

With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of...

      Related Stories 

Levorphanol Write-Down Dents Zydus in Q2 But Saroglitazar Expectations Build

Fri, 11/15/2019 - 12:28am

As returns from levorphanol fall on the back of increased competition, Zydus Cadila writes down investment by $37.5m causing Q2...

      Related Stories 

AZ, Omron Take China ‘Patient Journey’ Alliance Global

Thu, 11/14/2019 - 3:46pm

UK pharma giant’s head, International tells Scrip expanded alliance with diversified Japan group will develop solutions across the patient journey...

      Related Stories 

Sanofi Pasteur Head Loew On The Vaccine Unit's Future Growth Drivers

Thu, 11/14/2019 - 12:33pm

David Loew talked to Scrip about the next-generation meningococcal vaccine candidate MenQuadfi and a monoclonal antibody that may be the...

      Related Stories 

Pages